SCRIPT: parenteral poisons Flashcards
Introduction.
a) Paracelsus quote (16th century physician)
b) Give some potentially dangerous but commonly prescribed IV drugs
a) “All things are poison, and nothing is without poison, only the dose permits something not to be poisonous”
b) - Potassium chloride
- Insulin
- Gentamicin (and other aminoglycosides)
- Vancomycin
Hypokalaemia.
a) Severity grading
b) Presentation
c) Causes - drugs, other losses
a) - Mild: 3.0 - 3.5
- Moderate: 2.5 - 3.0
- Severe: < 2.5 (will require rapid correction)
b) - Asymptomatic
- muscle weakness and cramps, fatigue, constipation, and palpitations
- In more severe cases, heart arrhythmias
c) Drugs:
- Loop or thiazide diuretics
- Excessive use of laxatives
- Glucocorticoid therapy (e.g. prednisolone)
- Insulin
- Salbutamol
- Theophylline
- Some antibacterials (e.g. gentamicin, amphotericin)
Gastrointestinal losses:
- Diarrhoea
- Eating disorders (i.e bulimia)
- Malnutrition / malabsorption
- Vomiting
Other
- Mineralocorticoid excess (e.g. Cushing’s disease)
- Excessive alcohol consumption
- Renal Tubular acidosis
- Hypomagnesaemia*
*This should be corrected as it can make hypokalaemia resistant to treatment.
Hypokalaemia: management
a) Monitoring
b) Treatment
c) Maximum potassium concentration via peripheral vein
d) Maximum flow rate
a) - ECG monitoring
- Bloods: U+Es, magnesium levels*
*Correct if low, as needed for potassium rise
b) Pre-made potassium-containing fluids*:
- 1 litre bag of 0.9% NaCl + 40 mmol KCl (over at least 4 hours)**
OR
- 2x 500 ml bags of 0.9% NaCl/0.3% KCl (20 mmol in each bag)
- Only use pre-packaged fluids. Mis-selection of a strong potassium solution is a never event!
c) 40 mmol/L (any higher risks extravasation injury and tissue necrosis)
d) Rate should not generally exceed 10 mmol/hr
- In emergencies, may give up to 20 mmol/hr
(specialists may occasionally give higher rates, but there is an increased risk of cardiac arrest)
Hyperkalaemia.
a) Severity grading
b) Presentation
c) Causes - drugs, other losses
a) - Mild: 5.5* - 6.0
- Moderate: 6.0 - 6.5
- Severe: > 6.5 (or ECG changes)
*Or 5.3
b) - Nausea
- Muscle weakness
- Palpitations, ECG changes, arrhythmias, arrest
c) Drugs:
- ACE inhibitors/ ARBs
- Potassium sparing diuretics (e.g. spironolactone)
- Potassium supplementation (oral/intravenous)
- Digoxin toxicity
- Heparin and low molecular weight heparins
- NSAIDs
- Penicillins
- Trimethoprim
Other:
- Renal failure
- Dietary excess/supplementation
- Adrenal insufficiency
- Metabolic acidosis
- Burns, trauma, rhabdomyolysis, tumour lysi
ECG changes for:
a) Hypokalaemia - earliest sign, then…?
b) Hyperkalaemia - earliest sign, then…?
a) - First: flattening and inversion of T waves, followed by…
- Q-T interval prolongation
- visible U wave
- mild ST depression
b) - First: Tall tented T waves, followed by…
- Flattened / widened P waves
- Prolonged PR
- Prolonged QRS
- Sine wave
Hyperkalaemia: management
- cardioprotection
- potassium lowering
- monitoring
Firstly:
- A-E assessment
- Involve senior
- Gain IV access
- Baseline bloods taken
- Baseline ECG
Cardioprotect:
- 10 ml of calcium gluconate 10% solution, by slow IV injection over 3-5 minutes*.
- Titrate and adjust to ECG improvement.
- If the patient is taking digoxin, rapid administration of calcium gluconate may precipitate myocardial digoxin toxicity. The 10 ml of calcium gluconate 10% solution should be mixed with 100ml of glucose 5% and administered slowly over 20 minutes.
Potassium lowering:
- Stop any potassium supplementation
- Stop any potassium-retaining drugs
- Insulin/dex: 5-10 units Actrapid with 50 ml glucose 50%, given over 5-15 minutes
- Nebulised salbutamol (stop beta-blockers or digoxin if patient is on these?)
- Calcium resonium + lactulose
- If these measures fail, consider RRT
Monitoring:
- U+E
- ECG
Insulin.
a) Short-acting
b) Intermediate
c) Long-acting
a) - Used for bolus dosing, and in VRIII, and in SC insulin pumps.
- Examples: ActRapid, Humulin S, NovoRapid*
*Note: this is even quicker than short - it is rapid-acting
b) - Usually a twice-daily insulin
- Intermediate: Isophane, Humulin I, Insulatard
- Often mixed with a short-acting insulin (biphasic insulin)
- Mixed: NovoMix, Humulin M
c) - Usually OD or BD insulin
- Examples: insulin glargine, Lantus, Levemir
Patient with dementia admitted from a care home with a fall. You notice he is on insulin, but can find no record of his dosing.
a) Who should you contact?
a) - Care home: they should have insulin administration charts, so will be an accurate source
- If this fails, speak to GP, or community pharmacist, or relative or carers, etc.
Insulin: information to obtain in history
- The name of the insulin (as the brand name).
- Usual dose (or dose range) of insulin.
- The device used by the patient or their relative/carer to administer the insulin.
- The ‘usual’ time of administration.
- Whether they have an insulin passport or carbohydrate diary
Glucose readings.
a) Usual range pre-meal
b) Usual post-prandial ideal glucose
- Before meals: 4 - 7 mmol/litre.
- After meals: < 9 mmol/litre
Gentamicin.
a) Common indications
b) Contraindications
c) Routes of administration
d) Calculating dose
e) Monitoring levels
f) Toxicity - signs and treatment
a) - Neutropenic sepsis
- Gram negative sepsis
- Surgical prophylaxis
- Bacterial endocarditis
b) Myasthenia gravis
c) IV usually
- occasionally IM
d) - Actual body weight (ABW) usually
- Use IBW if the patient’s ABW is 20% heavier than ideal body weight (IBW) or has a BMI > 30
- Adult dose: 5-7 mg/kg/day as a single intravenous infusion over at least 1 hour
- Given as once-daily dose unless contraindicated or specialists advise mutliple-daily dosing
e) Nomograms*:
- Hartford nomogram, or Urban and Craig nomogram
- Generally measure level 6 - 14 hours after infusion started
- Nomogram will tell you how frequently dosing should be based on the serum level
- Repeat ~ every 3 days (more frequently in renal dysfunction or if dose needs changing)
*Generally used for once daily dosing
Pre- and post-dose**:
- 1 hour pre-dose (trough) and post-dose (peak)
- Trough target: usually < 1 mg/litre, or < 2 mg/litre (if trough level too high - increase dose interval)
- Peak target: usually 3 - 5 mg/litre, or 5 - 10 mg/litre (if peak level too high - reduce dose)
**Generally used for multiple daily dosing
f) Signs:
- Tinnitus/deafness/balance problems
- Nausea and vomiting
= Renal dysfunction
- Colitis
- Stomatitis
- Blood dyscrasias (e.g. neutropenia).
Treatment: haemodialysis
Calculating ideal body weight (IBW).
a) Calculation - in men, in women
b) When is IBW used?
a) IBW (in kg):
Men: [(height in cm - 154) x 0.9] + 50
Women: [(height in cm - 154) x 0.9] + 45.5
b) - Extremes of body weight (BMI > 30 or < 18.5)
- With drugs that have a narrow therapeutic window
Vancomycin.
a) Indications
b) Routes of administration
c) Dose calculation
d) Administration and risk mitigation
e) Monitoring
f) Possible adverse effects
a) - Gram-positive sepsis
- Neutropenic sepsis
- Prophylaxis/treatment of endocarditis
- ?MRSA
- C. diff (given orally - levels don’t need measuring)
b) - IV (not well-absorbed orally)
- Only given orally for c. diff
c) - Usually given twice-daily (as short half life of 5 - 7h)
d) - Give as SLOW infusion* to avoid red man syndrome, anaphylaxis or haemodynamic effects
- Ensure anaphylaxis medications are nearby in case of anaphylactic reaction
- If any adverse reaction, stop infusion immediately
- Antihistamine (eg. chlorphenamine) works well for red man syndrome
- dose should not exceed 10 mg/minute
- if 500 mg given, infuse over 50 minutes
- if 1 g given, infuse over 100 minutes
e) - Serum level taken 36 - 72 hours after starting treartment
- Pre-dose (trough) level needed
- Monitor renal function as vancomycin is nephrotoxic
- Note: do not need to take level if given orally, as systemic absorption from GI tract is negligible
f) - Blood dyscrasias
- Fever and chills
- Nausea and vomiting
- ‘Red man’ syndrome: this is more likely to occur if the infusion is administered too quickly
- Renal dysfunction
- Skin disorders (including TEN/SJS)
Gentamicin: interpretation of serum levels
a) Peak and trough levels
b) Nomograms
Trough target:
- trough level too high - increase dose interval
Peak target:
- if peak level too high - reduce dose